This book investigates the complex challenges in managing advanced Renal Cell Carcinoma (RCC), a disease resistant to conventional treatments like surgery, irradiation, and chemotherapy. It offers a comprehensive review of both the scientific underpinnings and clinical advancements in RCC research, with a particular focus on immunotherapy and immunobiology. The work compiles novel approaches aimed at improving treatment efficacy, even when definitive pre-clinical data is scarce, and presents preliminary findings from ongoing clinical trials involving biological modifiers. Special attention is given to recent progress in topical and subcutaneous cytokine-based immunotherapy.

This volume is structured to provide a thorough review of both the research and clinical aspects of Renal Cell Carcinoma, aiming to benefit professionals seeking a dual perspective. It highlights emerging strategies and preliminary findings from clinical trials, suggesting a focus on innovative and potentially less-explored treatment avenues. The book appears to be targeted at researchers and clinicians involved in oncology and nephrology, offering insights into the evolving landscape of RCC management.